📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: OncBioMune

1.1 - Company Overview

OncBioMune Logo

OncBioMune

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical medicines and vaccines to treat cancer and stimulate the immune system.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to OncBioMune

Endomag Logo

Endomag

HQ: United Kingdom Website
  • Description: Provider of magnetic sensing technologies for breast cancer care, including the Sentimag surgical guidance system to detect tumors and lymph nodes, Magseed markers for precise tissue and lymph node localization, Magtrace lymphatic tracer for sentinel node biopsy with clear signal and visual guidance, and Magseed Pro self-expanding seed for precise deployment and anchoring.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Endomag company profile →
Medifocus Logo

Medifocus

HQ: United States Website
  • Description: Provider of minimally invasive treatment systems for cancerous and benign tumors and enlarged prostate (BPH), developing and commercializing solutions based on two technology platforms with approximately 100 issued and pending US and international patents.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medifocus company profile →
Highlight Therapeutics Logo

Highlight Therapeutics

HQ: Spain Website
  • Description: Provider of an RNA-based immuno-oncology therapy, BO-112, designed to initiate an immune response against 'cold' tumors, making them 'hot' and visible to the immune system. Services include clinical development and trials (successful Phase 1 monotherapy, Phase 1b with anti-PD1), collaborations with Merck & Co and UCLA, and R&D into BO-112’s mechanism where checkpoint inhibitors are ineffective.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Highlight Therapeutics company profile →
Acerta Pharma Logo

Acerta Pharma

HQ: United States Website
  • Description: Provider of oncology and autoimmune drug discovery and development, including CALQUENCE (acalabrutinib) for CLL; collaborative small-molecule discovery for hematologic malignancies; innovative clinical studies; resistance biology research using multi-omic profiling; R&D on target identification and optimization; and partnering and in-licensing opportunities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acerta Pharma company profile →
Theranostics Health Logo

Theranostics Health

HQ: United States Website
  • Description: Provider of proteomics-based diagnostics and research services for drug development companies, developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor, utilizing Laser Capture Microdissection (LCM) and Reverse-phase Protein MicroArrays (RPMA) assays.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theranostics Health company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for OncBioMune

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to OncBioMune

2.2 - Growth funds investing in similar companies to OncBioMune

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for OncBioMune

4.2 - Public trading comparable groups for OncBioMune

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to OncBioMune

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About OncBioMune

What does OncBioMune do?

OncBioMune is a provider of biopharmaceutical medicines and vaccines to treat cancer and stimulate the immune system.

Who are OncBioMune's competitors?

OncBioMune's competitors and similar companies include Endomag, Medifocus, Highlight Therapeutics, Acerta Pharma, and Theranostics Health.

Where is OncBioMune headquartered?

OncBioMune is headquartered in United States.

How many employees does OncBioMune have?

OncBioMune has 1,000 employees 🔒.

When was OncBioMune founded?

OncBioMune was founded in 2010 🔒.

What sector and industry vertical is OncBioMune in?

OncBioMune is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for OncBioMune

Who are the top strategic acquirers in OncBioMune's sector and industry

Top strategic M&A buyers and acquirers in OncBioMune's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for OncBioMune?

Top strategic M&A buyers groups and sectors for OncBioMune include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in OncBioMune's sector and industry vertical

Which are the top PE firms investing in OncBioMune's sector and industry vertical?

Top PE firms investing in OncBioMune's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in OncBioMune's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in OncBioMune's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in OncBioMune's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to OncBioMune include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in OncBioMune's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for OncBioMune?

The key public trading comparables and valuation benchmarks for OncBioMune include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for OncBioMune for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for OncBioMune with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in OncBioMune's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for OncBioMune with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in OncBioMune's' sector and industry vertical?

Access recent funding rounds and capital raises in OncBioMune's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for OncBioMune